Mallinckrodt Announces New England Journal of Medicine Publication of Results from its Phase 3 CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1)
Ticker Tech,
-- CONFIRM is the largest prospective study (n=300) conducted in patients with HRS-1, a life-threatening and acute form of…